You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 98 No. 10, October 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (63)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognosis and Management of Corneal Transplantation for Herpetic Keratitis

L. Michael Cobo, MD; Douglas J. Coster, FRCS, FRACS; Noel S. C. Rice, MD, FRCS; Barrie R. Jones, FRCS, FRCP, FRACS

Arch Ophthalmol. 1980;98(10):1755-1759.


Abstract

• One hundred thirty-two penetrating keratoplasties (91 patients) for herpetic keratoplasty were reviewed retrospectively. The overall survival rate of clear keratoplasties to two years was 64% and to five years was 62%. The significant prognostic factors were preoperative ocular inflammatory status and degree of corneal vascularization. The two-year survival rate of a clear keratoplasty was 69% where eyes were inflamed at the time of surgery, compared with 44% in actively inflamed eyes. Allograft rejection, the major cause of a clouded herpetic keratoplasty, increased in frequency with increasing corneal vascularization. Antiviral cover was not used with routine postoperative steroids or with steroid intensive therapy for rejection. Epithelial herpetic recurrences occurred in 32% of eyes undergoing allograft rejection within four months of initiation of treatment for rejection. This is compared with otherwise uncomplicated keratoplasties where the epithelial recurrence rate was 6% at four months, on high-dose postoperative corticosteroid therapy without antiviral cover.



Author Affiliations

From the Institute of Ophthalmology, Department of Clinical Ophthalmology and Pathology, University of London, Moorfields Eye Hospital. Dr Cobo is now at Duke University Eye Center, Durham, NC.


Footnotes

Accepted for publication April 12, 1980.

Reprint requests to Duke University Eye Center, PO Box 3802, Durham, NC 27710 (Dr Cobo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Boston Keratoprosthesis in Herpetic Keratitis
Khan et al.
Arch Ophthalmol 2007;125:745-749.
ABSTRACT | FULL TEXT  

Tacrolimus immunosuppression in high-risk corneal grafts
Joseph et al.
Br J Ophthalmol 2007;91:51-55.
ABSTRACT | FULL TEXT  

Penetrating keratoplasty: outcomes from a corneal unit compared to national data
Beckingsale et al.
Br J Ophthalmol 2006;90:728-731.
ABSTRACT | FULL TEXT  

Penetrating keratoplasty: indications over a 10 year period
Al-Yousuf et al.
Br J Ophthalmol 2004;88:998-1001.
ABSTRACT | FULL TEXT  

The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
Halberstadt et al.
Br J Ophthalmol 2002;86:646-652.
ABSTRACT | FULL TEXT  

Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis
Tambasco et al.
Arch Ophthalmol 1999;117:445-449.
ABSTRACT | FULL TEXT  

Corneal transplantation for herpes simplex keratitis
LARKIN
Br J Ophthalmol 1998;82:107-108.
FULL TEXT  

Antiviral Therapy After Penetrating Keratoplasty for Herpes Simplex Keratitis
Moyes et al.
Arch Ophthalmol 1994;112:601-607.
ABSTRACT  

Recurrent Herpes Simplex Keratitis With Concurrent Epithelial and Stromal Involvement: Immunohistochemical and Ultrastructural Observations
Holbach et al.
Arch Ophthalmol 1991;109:692-695.
ABSTRACT  

Oral Acyclovir Reduces the Incidence of Recurrent Herpes Simplex Keratitis in Rabbits After Penetrating Keratoplasty
Beyer et al.
Arch Ophthalmol 1989;107:1200-1205.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.